Menu
Annual · values2025202420232022202120202019
Operating Cash Flow-5.05 B USD-9.51 M USD1.12 M USD-1.31 M USD-2.06 M USD6.12 M USD13.20 M USD
Depreciation & Amortization517.43 M USD485734 USD508785 USD533949 USD446878 USD410079 USD418431 USD
Stock-Based Compensation
Capital Expenditures266.77 M USD208320 USD44169 USD93703 USD444505 USD51798 USD86324 USD
Cash Flow from Investing-341.81 M USD-361285 USD-44169 USD-3.91 M USD-27.06 M USD-51798 USD-86033 USD
Cash Flow from Financing9.73 B USD33.95 M USD-1.39 M USD3.32 M USD26.58 M USD470136 USD-16.00 M USD
Dividends Paid16.00 M USD
Stock Buybacks
Free Cash Flow-5.32 B USD-9.72 M USD1.08 M USD-1.41 M USD-2.50 M USD6.06 M USD13.12 M USD

Universe Pharmaceuticals Inc. is a specialized company in the pharmaceutical industry focused on traditional Chinese medicine. The company's primary function is the manufacturing, marketing, and distribution of pharmaceuticals, with a significant portion of its products based on traditional Chinese herbal medicines. Universe Pharmaceuticals leverages ancient Chinese medical practices, integrating them with modern processing technologies to create a range of health and wellness products addressing various consumer needs. Notable features of Universe Pharmaceuticals include its extensive portfolio of over-the-counter medicine, dietary supplements, and skincare products that appeal to both domestic and international markets. With operations rooted in applying and preserving traditional knowledge, the company impacts sectors including healthcare, wellness, and consumer goods. In the context of financial markets, Universe Pharmaceuticals Inc. represents a blend of cultural heritage with contemporary scientific approaches, positioning itself uniquely as a bridge between traditional remedies and modern pharmaceuticals. Its presence in the market reflects growing consumer interest in alternative and holistic healthcare solutions, contributing to the diversification of the pharmaceutical industry.